Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series

OBJECTIVE: To describe clinical and imaging responses in neurosarcoidosis to infliximab, a monoclonal antibody against tumor necrosis factor–α. METHODS: Investigators at 6 US centers retrospectively identified patients with CNS sarcoidosis treated with infliximab, including only patients with defini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Gelfand, Jeffrey M., Bradshaw, Michael J., Stern, Barney J., Clifford, David B., Wang, Yunxia, Cho, Tracey A., Koth, Laura L., Hauser, Stephen L., Dierkhising, Jason, Vu, NgocHanh, Sriram, Subramaniam, Moses, Harold, Bagnato, Francesca, Kaufmann, Jeffrey A., Ammah, Deidre J., Yohannes, Tsion H., Hamblin, Mark J., Venna, Nagagopal, Green, Ari J., Pawate, Siddharama
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5711506/
https://ncbi.nlm.nih.gov/pubmed/29030454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000004644
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados